Subscribe for full access
Unlock Industry-grade Shariah Compliance for US, UK, Canada, Germany, GCC, Europe and India. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $3.99/month
Recommendation Rating
2
1
2
3
4
5
1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL
Analysts’ Price Targets
Mean 2.51
Low: 1.87
High: 2.97
Total Analysts: 2
Company Profile
Cambridge Cognition Holdings plc is a neuroscience technology company. The Company develops and markets digital solutions to assess brain health, principally in the United Kingdom, the United States and Europe. Its products include CANTAB Recruit, CANTAB Connect, Cognition Kit, Cognition eCOA, CANTAB Connect Research, CANTAB Mobile, CANTAB BrainHealth, CANTAB Insight, and NeuroVocalix. CANTAB Recruit is an online trial recruitment platform helping pharmaceutical and biotechnology companies identify qualified clinical trial participants in high-need indications, such as Alzheimer’s disease. CANTAB Connect offers digital cognitive assessment solutions for pharmaceutical clinical trials in therapeutic areas from phases I – IV. Cognition Kit is a custom-designed digital health platform delivering wearable and smartphone apps for high frequency data collection. It serves specialist contract research organizations, academic research institutions, and international healthcare providers.
We do our best to screen stocks as accurately as possible. Please let us know in the Community if you spot an error or find something questionable. Jazaak Allahu khairan.
